Clinical Trial

A Pilot Study on Reverse Aging (The REVERSE Study)

Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 21, 2026 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
Aging can be defined as a time-dependent functional decline in physiological function, which may increase the vulnerability to diseases and eventually death. The question is whether aging is a normal process, or exists as an "uber-illness?" Work done by Dr Sinclair at Harvard suggests the latter. Dr. Sinclair feels people should be able to age-in-place, or even reverse age. Aging is arguably the single biggest risk factor for all acquired and chronic diseases. Delaying the aging rate by 7 years would cut the incidence of chronic disease in half! Up until know the effects of anti-aging would need longitudinal studies until death. Now, with the advent of a 3rd generation OMIC Age clock, there is a way to assess if an intervention is changing the rate of aging and other methylation patterns associated with aging.
Trial Details
NCT Number NCT07354620
Lead Sponsor The Christ Hospital
Conditions Aging
Enrollment 52 participants
Start Date 2025-02-15
Primary Completion 2026-02 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2026-01-21